Brian H. Ladle

Also affiliated with Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Atezolizumab for Advanced Alveolar Soft Part Sarcoma”.

Atezolizumab for Advanced Alveolar Soft Part Sarcoma

New England Journal of Medicine(2023)10.1056/nejmoa2303383

N/A

3.3DataRank · unranked

158 citations

Elad Sharon, Geraldine O’Sullivan Coyne, Nancy Moore, Jared C. Foster, James Hu +26 more

Neoantigen-based EpiGVAX vaccine initiates antitumor immunity in colorectal cancer

JCI Insight(2020)10.1172/jci.insight.136368

N/A

1.1DataRank · unranked

35 citations

Xingyi Pan, Kevin C. Soares, Nilofer S. Azad, Nita Ahuja, Christopher Gamper +6 more

A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

Nature Medicine(2025)10.1038/s41591-025-03995-y

N/A

0.302DataRank · unranked

6 citations

Allison M. Kirk, Brian H. Ladle, Zeal Kamdar, Kayla J. Bendinelli, Won Jin Ho +23 more

Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout

Cancers(2025)10.3390/cancers17183068

N/A

0.208DataRank · unranked

3 citations

David Milewski, Lauren B. Banks, Kelly M. Bailey, Everett J. Moding, Jessica Lake +16 more

Towards directed therapy for fusion-positive rhabdomyosarcoma

Pharmacology & Therapeutics(2025)10.1016/j.pharmthera.2025.108931

N/A

0DataRank · unranked

3 citations

Sapna Oberoi, Brian H. Ladle, Raavi, Lars M. Wagner, Angela N. Koehler +2 more